Christine Carter-Kent

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc The role of lifestyle changes in the management of chronic liver disease
    Valerio Nobili
    Metabolic and Autoimmunity Liver Unit, Bambino Gesu Children s Hospital and Research Institute, S, Onofrio Square, 4, 00165 Rome, Italy
    BMC Med 9:70. 2011
  2. doi request reprint Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease
    Christine Carter-Kent
    Department of Pathology, Cleveland Clinic, USA
    J Pediatr Gastroenterol Nutr 52:190-7. 2011
  3. pmc Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD
    Angela Shannon
    Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, OH, USA
    J Pediatr Gastroenterol Nutr 53:190-5. 2011
  4. pmc Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study
    Christine Carter-Kent
    Department of Pediatric Gastroenterology and Nutrition, Cleveland Clinic, Cleveland, OH 44195, USA
    Hepatology 50:1113-20. 2009
  5. pmc Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
    Naim Alkhouri
    Department of Pediatric Gastroenterology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Expert Rev Gastroenterol Hepatol 5:201-12. 2011
  6. doi request reprint Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab
    Jonathan Moses
    Department of Pediatric Gastroenterology, Cleveland Clinic, Ohio, USA
    Am J Gastroenterol 107:133-8. 2012
  7. doi request reprint A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis
    Naim Alkhouri
    Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin Gastroenterol Hepatol 9:150-5. 2011
  8. doi request reprint Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment
    Christine Carter-Kent
    Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Am J Gastroenterol 103:1036-42. 2008

Collaborators

Detail Information

Publications8

  1. pmc The role of lifestyle changes in the management of chronic liver disease
    Valerio Nobili
    Metabolic and Autoimmunity Liver Unit, Bambino Gesu Children s Hospital and Research Institute, S, Onofrio Square, 4, 00165 Rome, Italy
    BMC Med 9:70. 2011
    ....
  2. doi request reprint Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease
    Christine Carter-Kent
    Department of Pathology, Cleveland Clinic, USA
    J Pediatr Gastroenterol Nutr 52:190-7. 2011
    ..The aims of the present study were to establish associations between steatosis amount, type, and distribution in a well-characterized group of children with biopsy-proven nonalcoholic fatty liver disease (NAFLD)...
  3. pmc Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD
    Angela Shannon
    Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, OH, USA
    J Pediatr Gastroenterol Nutr 53:190-5. 2011
    ..The aim of this study was to prospectively evaluate the clinical utility of ultrasonographic quantification of hepatic steatosis...
  4. pmc Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study
    Christine Carter-Kent
    Department of Pediatric Gastroenterology and Nutrition, Cleveland Clinic, Cleveland, OH 44195, USA
    Hepatology 50:1113-20. 2009
    ..003). CONCLUSION: Our results highlight the limitations of published proposals to classify pediatric NAFLD, and identified histological lesions associated with progressive disease...
  5. pmc Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
    Naim Alkhouri
    Department of Pediatric Gastroenterology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Expert Rev Gastroenterol Hepatol 5:201-12. 2011
    ..In particular, it will highlight the efforts for the development of both novel diagnostic and therapeutic strategies based on this knowledge...
  6. doi request reprint Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab
    Jonathan Moses
    Department of Pediatric Gastroenterology, Cleveland Clinic, Ohio, USA
    Am J Gastroenterol 107:133-8. 2012
    ..The objectives of this study were to determine HBV immunity in children with IBD on infliximab therapy and to determine response to a booster dose of the HBV vaccine in patients who were found to be non-immune...
  7. doi request reprint A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis
    Naim Alkhouri
    Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin Gastroenterol Hepatol 9:150-5. 2011
    ..We prospectively evaluated the performance of PNFI and ELF in assessing fibrosis in children with biopsy-proven NAFLD...
  8. doi request reprint Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment
    Christine Carter-Kent
    Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Am J Gastroenterol 103:1036-42. 2008
    ..We review the role of cytokines as key regulators of insulin sensitivity and hepatic lipid overloading, liver injury and inflammation, and fibrosis and cirrhosis, with an emphasis on potential therapeutic implications...